DJ IVD Medical May Continue Gaining Market Share in Hospitals -- Market Talk
0748 GMT - IVD Medical, which is the sole distributor for Sysmex hemostasis IVD products in China, may continue gaining market share in hospitals, Jefferies says. Jefferies initiates coverage on the stock with a buy rating and a target price of HK$5.00. IVD Medical already covers six out of eight IVD segments in China, the U.S. investment bank adds. The medical supplier may also start to expand its profit margins as it starts to increase the breadth of its product offerings, including its self-branded products, the bank says. Shares gain 3.2% to HK$2.92. (yiwei.wong@wsj.com)
(END) Dow Jones Newswires
July 23, 2020 03:48 ET (07:48 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
DJ IVD Medical可能继续扩大医院市场份额--市场谈话
0748GMT-Jefferies表示，作为Sysmex止血IVD产品在中国的独家分销商，IVD Medical可能会继续获得医院的市场份额。杰富瑞以买入评级及目标价5.00港元对该股发起覆盖。这家美国投资银行补充说，IVD Medical已经覆盖了中国八个IVD细分市场中的六个。世行表示，这家医疗供应商也可能开始扩大利润率，因为它开始增加产品供应的广度，包括自有品牌的产品。该公司股价上涨3.2%，至2.92港元。(yi wei.wong@wsj.com)
(完)道琼斯通讯社
2020年7月23日东部时间03：48(格林尼治标准时间07：48)
版权所有(C)2020道琼斯公司。
使用浏览器的分享功能，分享给你的好友吧